Role of CYP2A5 in the Bioactivation of the Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Mice

Documenti analoghi

• Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model
  di: Megaraj, Vandana, et al.
  Pubblicazione: (2014)
• Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse
  di: Li, Lei, et al.
  Pubblicazione: (2014)
• Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responses
  di: Alexandre, M., et al.
  Pubblicazione: (2012)
• Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers
  di: Stepanov, Irina, et al.
  Pubblicazione: (2008)
• Exposure to the Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Smokers from Three Populations with Different Risks of Lung Cancer
  di: Derby, Kiersten, et al.
  Pubblicazione: (2009)